Revenue
$975.3m
+6.5% ↑ vs $915.9m
The agri-sector earnings recovery is real at the operating line, but $23.8m of working-capital absorption pushed cash conversion to 22.1% and lifted
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
FY25 vs FY24
Revenue
$975.3m
+6.5% ↑ vs $915.9m
EBITDA
$56.1m
+27.1% ↑ vs $44.2m
Net profit after tax
$10.7m
+245.2% ↑ vs $3.1m
Net cash inflow from operating activities
$12.4m
-78.5% ↓ vs $57.7m
Full-year dividend per share
6.5c
— vs —
Operating profit
$26.2m
+70.5% ↑ vs $15.4m
Profit before tax
$14m
+164.2% ↑ vs $5.3m
Cash and cash equivalents
$2.6m
-31.0% ↓ vs $3.8m
What changed
NPAT of $10.7m (+245.2%) is flattered by the effective tax rate normalising to 23.8% from 42.5%, so PBT growth is the cleaner operating read.
Cash quality moved in the opposite direction. Operating cash flow fell 78.5% to $12.4m, and cash conversion (OCF/EBITDA) dropped to 22.1% from 130.7%. Operating working capital built by $23.8m, driven by a $19.4m rise in trade debtors to $129.0m. Gross borrowings rose 40% to $88.2m, taking net debt/EBITDA to 1.52x from 1.34x.
What matters
Capital raise adds balance-sheet context, with NZ$100m capital raised, but borrowings and gearing are the direct leverage evidence.
OCF/EBITDA at 22.1% versus 130.7% reflects $23.8m of working-capital absorption. Debtor days extended to 48.3 from 43.6, and free cash flow pre-lease swung to -$5.0m from +$34.9m. The reported earnings recovery is therefore not yet showing up in cash, which matters because the higher receivables balance has been funded with debt rather than internally generated cash.
The second half was loss-making. HY25 delivered $16.0m of NPAT and $41.4m of EBITDA. That means the implied H2 contribution was a $5.3m net loss on $14.8m of EBITDA, even though revenue was reasonably balanced (H1 took 58.5% of the year). The FY recovery is real but is concentrated in the first half, so projecting an H1 run-rate forward would overstate the underlying earnings trajectory.
Leverage stepped up. Gross borrowings rose to $88.2m and net debt/EBITDA moved to 1.52x. The increase funded working capital rather than capex, which fell 23.7% to $17.4m (1.8% of revenue). This narrows balance-sheet headroom if receivables do not release in FY26.
Expectations
Against the FY25 EBITDA guidance reaffirmed at HY25 ($51m), the delivered $56.1m is a modest beat. However, the very strong first-half / loss-making second-half shape means models built on H1 momentum risk overstating run-rate earnings.
The H2 swing is what matters most for setting FY26 expectations: it suggests either seasonal phasing different from FY24 or genuine softness in the back half of the year. Without forward-work disclosure or a stated FY26 target, the release does not support a clean projection of either earnings or cash conversion into next year.
Quality of result
PBT growth of 164.2% from a low FY24 base, combined with EBITDA margin expansion, reflects improving conditions in the agri-sector. NPAT growth of 245.2% overstates progress because the prior period carried an unusually high 42.5% effective tax rate; the 23.8% current ETR is closer to a normal run-rate, so the cleaner operating read is PBT.
Cash quality is the weak link. Working-capital absorption of $23.8m exceeded the entire year's NPAT and pushed FCF pre-lease to -$5.0m, giving FCF/NPAT of -47.2%. The full-year dividend of 6.5cps (final 4.0cps) was not covered by free cash flow on a pre-lease basis, and the cash shortfall plus higher trade debtors was funded by additional debt drawn during the year. The 46.1% NPAT payout ratio looks moderate on the income statement but understates the cash strain because reported NPAT is itself not converting to cash. On a durability read, the earnings recovery is exposed to continued agri-sector improvement and to whether H2 weakness persists, while the cash result is balance-sheet-assisted rather than self-generated.
Unresolved
This briefing cannot assess whether the H2 weakness reflects seasonal phasing or trend deterioration, because the release does not provide a segmental or category walk between H1 and the implied H2.
Chat
Ask follow-up questions about PGG Wrightson's FY25 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
PGW Financial Statements_FY to 30 June 2025
FY25 / financial reportPGW NZX Template Results Announcement FY to 30 June 2025
FY25 / results announcementPGW Results Announcement FY to 30 June 2025
FY25 / results releaseAnnual Report for Financial Year to 30 June 2024
FY24 / financial reportSustainability Report for Financial Year to 30 June 2024
FY24 / results announcementSustainability Report for Financial Year to 30 June 2024
FY24 / results releaseNZX Results Announcement Format to 31 December 2024
HY25 / results announcementPGW Half Year Report to 31 December 2024
HY25 / financial reportPGW Half Year Results Announcement to 31 December 2024
HY25 / results releasePGW HY Presentation to 31 December 2024
HY25 / results presentationPGW Guidance Update
FY24 / commentaryPGW Guidance Update
FY24 / commentaryAnnual Shareholders Meeting Presentation 2024
HY25 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Cash conversion quality
This result converted 22.1% of EBITDA to operating cash flow, -108.6pp versus the prior comparable period.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 81.0pp, with a distortion flag in the result.
Dividend coverage and payout pressure
Dividend payout versus NPAT is 46.1%.
Leverage and balance-sheet risk
Net debt / EBITDA is 1.52x, +0.18x versus the prior comparable period.
Get the next PGG Wrightson briefing and related NZX reporting-season updates by email.